Company sniffs unique opportunity with nasal COVID-19 vaccine

With a new CEO at the helm and a radical pivot in product strategy, Tampa-based Oragenics has taken risks that, if successful, could make it the next big name in pharmaceuticals.

  • By Brian Hartz
  • | 6:10 p.m. August 10, 2022
  • | 0 Free Articles Remaining!
Kim Murphy was named CEO of Oragenics in June. (Photo by Mark Wemple)
Kim Murphy was named CEO of Oragenics in June. (Photo by Mark Wemple)
  • Health Care
  • Share

For people who dread the prospect of getting COVID-19 vaccines and booster shots via needles, a Tampa pharmaceutical firm might bring to market a product that can soothe their fears.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • December 13, 2025
Report: Small business optimism up, but worries percolate
  • December 12, 2025
CEO of Bradenton EDC announces retirement
  • December 12, 2025
Manatee County to break ground on $40M veterans complex
  • December 12, 2025
Moez Limayem confirmed as USF’s new president

Sponsored Content